Nerve Growth Factor (NGF) Market: Overview

Nerve growth factor (NGF) is a protein responsible for the development and maintenance of sensory and sympathetic neurons, especially the neurons that transmit touch, temperature, and pain sensation. Studies have shown that nerve growth factor causes axonal growth via axonal branching and elongation. The nerve growth factor gene responsible for the secretion of NGF is referred to by names such as beta-nerve growth factor, HSAN5, beta-NGF, nerve growth factor, beta subunit, beta-nerve growth factor precursor, NGFB, and NGF_HUMAN. The NGF protein acts by attaching to the receptors, which kick off the signaling pathway within the cell. The binding of NGF on receptors signals the neuron to develop, mature, and take on the specialized function. It also blocks the signals that initiate apoptosis. Nerve growth factor was first discovered by Levi-Montalcini, Hamburger, and Cohen in 1953 in two mouse sarcomas. 

Report Overview: https://www.transparencymarketresearch.com/nerve-growth-factor-mark...

NGF is important for the survival of sensory and sympathetic neurons. It plays a major role in the reduction of neural degeneration. It can be of significant use in inflammatory diseases, where it suppresses inflammation, and in the treatment of multiple sclerosis and  psychiatric disorders such as depression, dementia,  schizophrenia,  rett syndrome, autism, anorexia nervosa, and bulimia nervosa. NGF also plays a role in coronary atherosclerosis, type 2 diabetes, obesity, wound healing, and metabolic syndrome. In few gynecological diseases, an increased level of prostaglandin E2 is thought to stimulate the production of NGF, which is responsible for the perception of pain and increased inflammation in endometriosis. An increased level of cortical and subcortical NGF is found in patients with Alzheimer’s disease. 

The nerve growth factor market can be segmented based on application and region. Based on application, the nerve growth factor market can be segmented into central neurodegenerative diseases, peripheral neuropathies, autoimmune diseases, and others. In terms of region, the nerve growth factor market can be categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. 

Request Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B...

North America  and Europe are prominent regions of the nerve growth factor market, due to high incidence and prevalence rate of  neurodegenerative diseases in the regions. According to the McGovern Institute for Brain Research at MIT, brain disorders contribute significantly to the global disease burden. It has been estimated that in Europe, brain disorders account for around 35% of the disease burden. More than one million adults in the U.S. are diagnosed with chronic brain diseases and disorders. Thus, this large base of brain patients is expected to drive the nerve growth factor market in the region. However, other regions such as South East Asia, Middle East, and Latin America are expected to offer expansion potential for the nerve growth factor market in the future. This is due to a high incidence rate of brain diseases and high adoption rate for advanced therapeutics In these regions. 

The nerve growth factor market is being driven by a rise in the incidence rate of brain diseases and increase in the geriatric population. Expected technological breakthroughs are estimated to offer attractive opportunities for detecting targeted blockages, monitoring cellular response, and for determining genetic predisposition. This is likely to drive the nerve growth factor market. However, a rise in stringent regulatory policies, increase in overall health care expenditure, and high costs of clinical trials are some of the factors that are projected to restrain the nerve growth factor market in the near future. 

Major players operating in nerve growth factor market include Merck KGaA, Promega Corporation, Alomone Labs, Bio-Rad Laboratories, Inc., Enzo Life Sciences, Inc., Prospec-Tany Technogene Ltd., CUSABIO TECHNOLOGY LLC, and Biocare Medical, LLC.

Pre Book: https://www.transparencymarketresearch.com/checkout.php?rep_id=5797...

More Trending Reports by Transparency Market Research:

https://www.prnewswire.com/news-releases/trauma-implants-market-to-...;

https://www.prnewswire.com/news-releases/skin-care-devices-market-t...

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information, we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem-solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.”

Contact

Transparency Market Research

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

USA - Canada Toll Free: 866-552-3453

Email: [email protected]

Website: https://www.transparencymarketresearch.com